Published January 6, 2018

Monash University's Biomedicine Discovery Institute scientists have defined a novel molecular “blueprint” that plays a pivotal part in the immune system's ability to fight disease by “remembering” infections.

Read More

Published January 4, 2018

Researchers identified nearly 40,000 cancer patients who had received opioid prescriptions following surgery intended to eradicate the cancer. Doctors generally expect patients to take these drugs for no more than two weeks after surgery. But the study found that three months after surgery, 10% of the patients were continuing to take high levels of opioids. Those who received chemotherapy after the surgery had an even greater risk, with 15% to 21% continuing to take high doses longer than recommended.

Read More

Published January 2, 2018

Researchers examined national registry data to look for correlations between warfarin use and cancer incidence and found that using warfarin was associated with a lower risk of prostate, lung, and breast cancer, three of the most common forms of the disease. The risk was actually lowest of all for the people using warfarin for a heart condition.

Read More